| 121/150 | US=35 / Câncer Mesa RA, Kaufmann SH. Molecular foundations of AML pathogenesis and physiology: altered apoptosis in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 133-61. ISBN 978-1-58829-621-4. LEUCEMIA MIELOGENA AGUDA; APOPTOSE; RESISTENCIA MEDICAMENTOSA; BCL-2; MCL-1; XIAP; MICROAMBIENTE DA MEDULA OSSEA; RAS; FLT3 |
| 122/150 | US=35 / Câncer Ross DD. Molecular foundations of AML pathogenesis and physiology: drug resistance transporters in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 163-73. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOGENA AGUDA; TRANSPORTADORES DE RESISTENCIA DE DROGAS |
| 123/150 | US=35 / Câncer Grimwade D. Translating biology into clinical application: impact of cytogenetics on clinical outcome in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 177-92. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOGENA AGUDA; BIOLOGIA; APLICACAO CLINICA; CITOGENETICA; REARRANJOS CROMOSSOMICOS CRIPTICOS; HIBRIDACAO IN SITU FLUORESCENTE; TRIAGEM MOLECULAR; ESTRATIFICACAO DE RISCO; DISSOMIA UNIPARENTAL ADQUIRIDA |
| 124/150 | US=35 / Câncer Frankfurt O, Peterson LC, Gallagher R, Tallman MS. Translating biology into clinical application: APL: a classic tale of bench to bedside. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 193-228. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA PROMIELOCITICA AGUDA; LEUCEMIA MIELOIDE AGUDA; PML-RARALFA; COAGULOPATIA; ACIDO RETINOICO; TRIOXIDO ARSENICO; SINDROME DO ACIDO RETINOICO |
| 125/150 | US=35 / Câncer Sausville EA. Molecular therapeutics of AML: selected targeted approaches: emerging therapeutics for AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 231-46. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; EMERGENCIAS TERAPEUTICAS; NOVOS AGENTES; TERAPIA ALVO; VACINA; SINALIZACAO VEGF; ADAFOSTINA; TRITERPENOIDES |
| 126/150 | US=35 / Câncer Levis M. Molecular therapeutics of AML: FLT3: a prototype receptor tyrosine kinase target in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 247-61. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; QUINASE; FLT3; PROGNOSTICO; INIBIDORES; CELULAS TRONCO |
| 127/150 | US=35 / Câncer Lancet JE. Molecular therapeutics of AML: farnesyl transferase inhibitors in the therapy of AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 263-74. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; FARNESILACAO; INIBIDORES DE FARNESITRANSFERASE; TRANSDUCAO DE SINAL |
| 128/150 | US=35 / Câncer Fandy T, Carraway H, Gore SD. Molecular therapeutics of AML: modulating gene expression as a therapeutic approach in the treatment of AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 275-91. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; METILACAO DO DNA; AGENTE DEMETILANTE; 5-AZACITIDINA; INIBIDOR DA HISTONA DEACETILASE; PROMOTOR HIPER-METILACAO; HISTONA ACETILTRANSFERASE; HISTONA METILTRANSFERASE; DECITABINA |
| 129/150 | US=35 / Câncer Lin TL, Matsui W. Molecular therapeutics of AML: differentiation therapy in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 293-312. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; TERAPIA DIFERENCIADA; SINDROME MIELODISPLASICA; FATORES DE CRESCIMENTO; CICLO CELULAR; ACIDO RETINOICO; VITAMINA D; METILACAO DO DNA; BRIOSTATINA 1 |
| 130/150 | US=35 / Câncer Bolaños-Meade J, Jones RJ. Molecular therapeutics of AML: stem cell transplantation for AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 313-27. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; TRANSPLANTE DE CELULAS TRONCO; SINDROME MIELODISPLASICA; LEUCEMIA PROMIELOCITICA; TRANSPLANTE DE MEDULA OSSEA; DOENCA ENXERTO VERSUS HOSPEDEIRO |
| 131/150 | US=35 / Câncer Borrello I. Molecular therapeutics of AML: tumor vaccines in leukemia. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 329-41. (Contemporary Hematology) ISBN 978-1-58829-621-4. |
| 132/150 | US=35 / Câncer Arceci RJ. Special challenges: treatment, outcomes, and challenges of newly diagnosed AML in children and adolescents. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 345-72. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; CRIANCA; ADOLESCENTE; PREDISPOSICAO HEREDITARIA; SINDROMES FAMILIARES; INSTABILIDADE CROMOSSOMICA; METABOLISMO DA DROGA; ESTRATIFICACAO DO GRUPO DE RISCO |
| 133/150 | US=35 / Câncer Stone RM. Special challenges: AML in older adults. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 373-84. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; ADULTO; LEUCEMIA MIELOIDE AGUDA. DIAGNOSTICO; LEUCEMIA MIELOIDE AGUDA. CLASSIFICACAO; LEUCEMIA MIELOIDE AGUDA. PROGNOSTICO; LEUCEMIA MIELOIDE AGUDA. TRATAMENTO |
| 134/150 | US=35 / Câncer Gotlib J. Special challenges: dameshek smiles: molecular clues to the chronic myeloproliferative disorders unmasked. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 385-98. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; DOENCAS REUMATICAS CRONICAS; JAK2 V617F; POLICITEMIA VERA; TROMBOCITEMIA ESSENCIAL; MIELOFIBROSE IDIOPATICA; DOENCA MIELOPROLIFERATIVA |
| 135/150 | US=35 / Câncer Estey E. Special challenges: new designs for clinical trials. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 399-415. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; ENSAIOS CLINICOS; 3 PROJETO 3; MODELOS DE DUAS FASES CONVENCIONAIS; METODOLOGIA BAYESIANA |
| 136/150 | US=49-B / Câncer Hu J, Zhou GB, Wang ZY, Chen SJ, Chen Z. Mutant transcription factors and tyrosine kinases as therapeutic targets for leukemias: from acute promyelocytic leukemia to chronic myeloid leukemia and beyond. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2007. p. 191-220. ISBN 978-0-12-373896-7. FATORES DE TRANSCRICAO MUTANTES; TIROSINA QUINASES; LEUCEMIAS; LEUCEMIA PROMIELOCITICA AGUDA; LEUCEMIA MIELOIDE CRONICA |
| 137/150 | US=32 / Biol/Mol Knudsen S. Leukemia. In: ___. Cancer diagnostics with DNA microarrays. New Jersey: John Wiley & Sons, 2006. p. 97-103. ISBN 978-0-471-78407-4. |
| 138/150 | US=55 / Biol/Mol Avramis VI. NONMEM population models of cytosine arabinoside and fludarabine phosphate in pediatric patients with leukemia. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 331-52. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5. NONMEM; CITOSINA DE ARABINOSIDE; FOSFATO DE FLUDARABINA; PACIENTES PEDIATRICOS; LEUCEMIA; LEUCEMIA LINFOBLASTICA AGUDA; VOLUME DE DISTRIBUICAO |
| 139/150 | US=6 / Pediatria Wall DA, Schultz KR, Reid GSD. Malignant diseases: transplantation for childhood acute lymphoblastic leukemia. In: Kline RM. Pediatric hematopoietic stem cell transplantation. New York: Informa Helthcare, 2006. p. 477-95. ISBN 978-0-8247-2445-3. DOENCAS MALIGNAS; LEUCEMIA LINFOBLASTICA AGUDA; TRANSPLANTE; FONTE DE CELULAS-TRONCO HEMATOPOETICAS; ENXERTO |
| 140/150 | US=6 / Pediatria Chen AR, Arceci RJ. Malignant diseases: bone marrow transplantation for acute myeloid leukemia in children. In: Kline RM. Pediatric hematopoietic stem cell transplantation. New York: Informa Helthcare, 2006. p. 497-528. ISBN 978-0-8247-2445-3. DOENCAS MALIGNAS; TRANSPLANTE DE MEDULA OSSEA; LEUCEMIA MIELOIDE AGUDA; CRIANCAS; LEUCEMIA MIELOIDE AGUDA. FATORES DE RISCO; LEUCEMIA MIELOIDE AGUDA. PROGNOSTICO; TRANSPLANTE ALOGENICO; TRANSPLANTE AUTOLOGO |